Leadership Overview
Arthrex has 6 executives leading key functions including operations, finance, ownership, agency management, and board oversight.
Driven by innovation, Arthrex is dedicated to advancing orthopedic surgery through cutting-edge products and comprehensive medical education, impacting patient care globally.
Driven by innovation, Arthrex is dedicated to advancing orthopedic surgery through cutting-edge products and comprehensive medical education, impacting patient care globally.
Leadership Roles at Arthrex
Marie Stewart - Chief Financial Officer
Marie Stewart, the Chief Financial Officer at Arthrex, manages the company's comprehensive financial strategy and operations. This includes overseeing all fiscal planning, budgeting, and financial reporting to ensure robust economic health and sustainable growth. Stewart directs investment strategies, allocating capital to research and development for new orthopedic products and expanding medical education initiatives. The Chief Financial Officer's purview encompasses risk management, ensuring financial compliance across all global operations and safeguarding company assets. By meticulously analyzing financial performance, Marie Stewart provides critical insights that inform executive decision-making and strategic planning. This leadership ensures Arthrex maintains its financial stability while pursuing innovation in the medical device sector.
Madyson Massad - Chief Operating Officer
Madyson Massad, the Chief Operating Officer at Arthrex, directs the company's extensive operational framework. This leadership involves optimizing the supply chain for orthopedic devices and ensuring efficient production processes that meet the high demands of surgeons worldwide. Massad oversees the integration of new technologies into manufacturing, driving improvements in product quality and delivery timelines. The Chief Operating Officer's responsibilities extend to managing global logistics, ensuring seamless distribution of Arthrex's specialized orthopedic products across various international markets. By focusing on operational excellence, Madyson Massad supports the company's mission to provide surgeons with innovative solutions for patient care. This role is critical for maintaining Arthrex's reputation for reliability and advanced medical education delivery.
Chadwick Cooper - Owner and President
Chadwick Cooper, the Owner and President at Arthrex, provides overarching leadership and strategic direction for the organization. This executive role involves setting the company's vision and guiding its expansion within the global orthopedic market. Cooper's responsibilities include fostering a culture of innovation and excellence, essential for developing advanced medical devices and educational programs. The Owner and President's influence extends to key business development initiatives and strategic partnerships that enhance Arthrex's market position. By championing the company's core values, Chadwick Cooper ensures alignment across all departments, driving forward the mission to improve patient outcomes through superior orthopedic solutions. This leadership is fundamental to Arthrex's sustained success and industry impact.
Chris Donnelly - President
Chris Donnelly, the President at Arthrex, drives strategic initiatives and operational execution across key business segments. This leadership position involves overseeing the development and implementation of programs designed to advance orthopedic surgery through innovative products and comprehensive surgeon education. Donnelly's focus includes enhancing market penetration and ensuring the effective delivery of Arthrex's specialized offerings to healthcare professionals globally. The President's role requires close collaboration with other executive leaders to align departmental goals with the company's overarching mission. By directing critical business functions, Chris Donnelly contributes significantly to Arthrex's growth and its commitment to improving patient care through cutting-edge medical technology.

Curt Reekers - Agency Owner and President
Curt Reekers, the Agency Owner and President at Arthrex, directs the strategic vision and operational management of the agency's functions. This executive capacity involves guiding the agency's growth and ensuring its alignment with Arthrex's broader objectives in medical device innovation and surgeon education. Reekers oversees the development and execution of market strategies, focusing on expanding reach and impact within the orthopedic sector. The Agency Owner and President's responsibilities include fostering strong relationships with key stakeholders and driving initiatives that enhance service delivery. By leading the agency with a focus on excellence, Curt Reekers plays a vital role in supporting Arthrex's mission to provide surgeons with advanced solutions that improve patient care.
Jennifer Ciesinski - Director At Large
Jennifer Ciesinski, the Director At Large at Arthrex, provides strategic oversight and guidance across various organizational initiatives. This leadership role involves contributing to high-level decision-making and ensuring the effective implementation of corporate strategies. Ciesinski's responsibilities include advising on key projects and programs that support Arthrex's mission to advance orthopedic surgery through innovative products and medical education. The Director At Large's input is crucial for maintaining operational integrity and fostering a culture of continuous improvement. By offering broad perspective and strategic insight, Jennifer Ciesinski supports the executive team in navigating complex challenges and driving the company's sustained success in the medical device industry.
Explore Leadership Teams in Manufacturing
Headquartered in North Carolina, Medical Manufacturing Technologies (MMT) offers manufacturing-as-a-service that brings together applications expertise, technical solutions, and aftermarket support to revolutionize medical device manufacturing.
Company Leadership
RS
TS
VS
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Company Leadership


DS
Carestream Dental is transforming dentistry, simplifying technology and changing lives around the world with its innovative digital product line of systems, solutions and support. From intraoral and extraoral imaging equipment to CAD/CAM solutions, imaging analysis software to practice management systems, Carestream Dental technology captures two billion images annually and aids in more precise diagnoses, improved workflows and superior patient care.
Company Leadership

AV
CT
Nipro Corporation, headquartered in Osaka, Japan, has been a provider in medical products to the healthcare community for over 50 years. In addition to Nipro-branded products, Nipro provides manufacturing support to companies in the medical field.
Company Leadership SA
DR
SG